Benzinga | Mar 18, 2021 04:18PM EDT

Alpine Immune Sciences Q4 EPS $(0.27) Beats $(0.31) Estimate, Sales $5.64M Beat $2.59M Estimate

Alpine Immune Sciences (NASDAQ:ALPN) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.31) by 12.9 percent. This is a 18.18 percent increase over losses of $(0.33) per share from the same period last year. The company reported quarterly sales of $5.64 million which beat the analyst consensus estimate of $2.59 million by 117.88 percent. This is a 538.35 percent increase over sales of $884.00 thousand the same period last year.